Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
The government announced back in October that the Education Maintenance Allowance (EMA) which provided means-tested grants of up to £30 a week to help young people stay on at school or college was to be scrapped. The £180 million fund which is to replace the scheme would instead be allocated by colleges at their own discretion.
An MP select committee, whilst recognising the need to scrap the EMA, has criticised the execution of its replacement. Colleges did not receive their allocations until June which is too late for this year’s cohort of 15-16 year olds starting courses in September. Most would have submitted their applications well in advance.
The new scheme has also come in for criticism and is likely to result in wide ranging inconsistencies. Savvy colleges may be able to use the fund to attract more students defeating the overall aim of the fund, that is to support those most in need. This is not likely to be the last we hear of the new bursary fund.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner
Select which mailings you would like to receive from us.
Sign up